# Study of SCB01A in Patient With Head and Neck Cancer

> **NCT02488629** · PHASE2 · TERMINATED · sponsor: **SynCore Biotechnology Co., Ltd.** · enrollment: 5 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** SCB01A

## Key facts

- **NCT ID:** NCT02488629
- **Lead sponsor:** SynCore Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02488629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02488629, "Study of SCB01A in Patient With Head and Neck Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02488629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*